echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The top list of pharmaceutical companies' revenue is released!

    The top list of pharmaceutical companies' revenue is released!

    • Last Update: 2022-05-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Enterprise development is like "going against the current, if you don't advance, you will retreat", especially for pharmaceutical companies under the new crown epidemic

    .


    The pharmaceutical industry has largely recovered from the pandemic in 2021 due to revenue growth driven by the new crown business

    .
    Recently, Fierce Pharma released the top 20 pharmaceutical companies by global revenue in 2021

    .
    Data shows that last year, all the top 20 pharmaceutical companies in the world achieved positive revenue growth!


    Table 1.
    Top 20 pharmaceutical companies by global revenue in 2021


    Source: References


    Among the top 20 pharmaceutical companies by revenue, 11 had sales growth of more than 10%, and five of them had sales growth of more than 40%, namely BioNTech, Moderna, Pfizer, Viatris and AstraZeneca

    .


    In 2020, 6 of the top 20 pharmaceutical companies experienced revenue declines

    .
    Only two companies grew revenue by more than 10%, and those gains were almost entirely attributable to major acquisitions

    .


    Unlike in 2020, we can see that the three companies with the fastest revenue growth in 2021 will all benefit a lot from new crown products

    .
    Among them, Pfizer nearly doubled its revenue, driven by its mRNA Covid-19 vaccine Comirnaty

    .
    Moreover, this year, Pfizer is expected to get $54 billion in sales revenue from the Comirnaty vaccine and its new crown oral drug Paxlovid, and the total revenue is expected to surpass Johnson & Johnson and win the championship

    .


    In addition to BioNTech and Moderna, which are on the list with their new crown products, there is also a new generic drug company-Viatris

    .
    The company, formed by the merger of Mylan and Pfizer Upjohn in 2020, which derives most of its revenue from generics, overtook Teva as the only generic company to make the list

    .


    AstraZeneca's revenue growth was mainly driven by last year's $39 billion acquisition of Alexion and the new crown vaccine Vaxzevria

    .


    Another company with faster revenue growth is AbbVie, which achieved 23% revenue growth without COVID-19-related products, ranking fourth

    .
    The reason is that the annual sales of its star drug Humira exceeded the $20 billion mark for the first time

    .


    Merck also saw its revenue rise 17% on higher sales of its blockbuster drug Keytruda

    .


    On the other hand, Teva, Biogen and Astellas fell out of the Top 20 list due to lower-than-expected sales revenue

    .
    Among them, Biogen's revenue plunged 18% due to dismal sales of its controversial new Alzheimer's drug Aduhelm

    .

    If this article violates your rights, please contact us
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.